Clinical Trial Update: Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update on targeted T cells after neoadjuvant chemotherapy in women with stage II or III breast cancer undergoing surgery has been terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-04-27